Related Experiment Video
Updated: Jul 16, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
Cyclosporine A- and FK506-induced apoptosis in PC12 cells
T Takadera1, Y Sakamoto, Y Hizume
1Department of Clinical Chemistry, Faculty of Pharmaceutical Sciences, Hokuriku University, Ho-3, Kanagawa-machi, Kanazawa, Ishikawa, 920-1148, Japan. t-takadera@hokuriku-u.ac.jp
Abstract:
The purpose of this study was to examine, using glycogen synthase kinase (GSK) inhibitors, whether GSK-3 is involved in cyclosporine A (CsA)- and FK506-induced apoptosis in PC12 cells. CsA and FK506 increased apoptotic cell death with morphological changes characterized by cell shrinkage and nuclear condensation or fragmentation. Nerve growth factor (NGF) completely blocked cell death. Caspase-3 activation was accompanied by CsA- and FK506-induced cell death and inhibited by NGF. GSK-3 inhibitors such as alsterpaullone and SB216763 prevented CsA- and FK506-induced apoptosis. These results suggest that CsA and FK506 induce caspase-dependent apoptosis and that GSK-3 activation is involved in CsA- and FK506-induced apoptosis in PC12 cells.
Insights
Cyclosporine A (CsA) and FK506 trigger apoptosis in PC12 cells via caspase-3 activation. Glycogen synthase kinase-3 (GSK-3) activation is involved in this process, and its inhibition prevents cell death.
Area of Science:
- Neuroscience
- Cell Biology
- Pharmacology
Background:
- Cyclosporine A (CsA) and FK506 are immunosuppressants known to induce cell death.
- Apoptosis, or programmed cell death, is a critical cellular process.
- PC12 cells are a neuronal cell line frequently used in apoptosis research.
Purpose of the Study:
- To investigate the role of glycogen synthase kinase-3 (GSK-3) in CsA- and FK506-induced apoptosis.
- To determine if GSK-3 activation is a key mediator in the apoptotic pathway triggered by these compounds.
Main Methods:
- PC12 cells were treated with CsA and FK506 to induce apoptosis.
- Morphological changes indicative of apoptosis were observed.
- The activation of caspase-3 was measured.
- GSK-3 inhibitors (alsterpaullone, SB216763) were used to block GSK-3 activity.
- Nerve growth factor (NGF) was used as a protective agent.
Main Results:
- CsA and FK506 induced significant apoptotic cell death in PC12 cells, characterized by cell shrinkage and nuclear fragmentation.
- Nerve growth factor (NGF) completely protected PC12 cells from CsA- and FK506-induced apoptosis.
- Caspase-3 activation was observed concurrently with CsA- and FK506-induced cell death and was inhibited by NGF.
- Inhibition of GSK-3 using alsterpaullone and SB216763 effectively prevented CsA- and FK506-induced apoptosis.
Conclusions:
- CsA and FK506 induce apoptosis in PC12 cells in a caspase-dependent manner.
- GSK-3 activation plays a crucial role in the apoptotic process initiated by CsA and FK506 in PC12 cells.
- Targeting GSK-3 may offer a therapeutic strategy to mitigate CsA- and FK506-induced cellular damage.
Related Concept Videos
The Extrinsic Apoptotic Pathway
Inhibition of Cdk Activity
The Intrinsic Apoptotic Pathway
Caspases

